Patents Examined by Yong Pak
  • Patent number: 8658406
    Abstract: The present invention provides a novel endoglucanase nucleic acid sequence, designated egl7, and the corresponding EGVII amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVII, recombinant EGVII proteins and methods for producing the same.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: February 25, 2014
    Assignee: Danisco US Inc.
    Inventors: Nigel Dunn-Coleman, Frits Goedegebuur, Michael Ward, Jian Yao
  • Patent number: 8652820
    Abstract: This invention relates to cloning and sequencing of thermotolerant phytase gene from Non-K12 Escherichia coli strain, ATCC 9637, phytase gene expression in Escherichia coli expression system, codon usage optimized and expression in Pichia pastoris, Pichia methanolica and Kluyeromyces lactis. The high level yield and thermotolerant enzyme was produced from fermentation of Pichia pastoris with optimized codon of phytase gene.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: February 18, 2014
    Assignee: Fujian Fuda Biotech Co. Ltd.
    Inventors: Xiuyun Ye, Renkuan Li, Weigang Jin, Caifang Chen
  • Patent number: 8637295
    Abstract: The invention relates to mutants of coryneform bacteria in which genes have been enhanced by the use of a mutated promoter region, and to processes for the production of amino acids using bacteria according to the invention.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: January 28, 2014
    Assignee: Evonik Degussa GmbH
    Inventors: Wilfried Claes, Brigitte Bathe
  • Patent number: 8637293
    Abstract: Provided herein is an isolated Cel7A polypeptide comprising mutations in the catalytic domain of the polypeptide relative to the catalytic domain of a wild type Cel7A polypeptide, wherein the mutations reduce N-linked glycosylation of the isolated polypeptide relative to the wild type polypeptide. Also provided herein is an isolated Cel7A polypeptide comprising increased O-linked glycosylation of the linker domain relative to a linker domain of a wild type Cel7A polypeptide. The increased O-linked glycosylation is a result of the addition of and/or substitution of one or more serine and/or threonine residues to the linker domain relative to the linker domain of the wild type polypeptide. In some embodiments, the isolated Cel7A polypeptide comprising mutations in the catalytic domain of the polypeptide relative to the catalytic domain of a wild type Cel7A polypeptide further comprises increased O-linked glycosylation of the linker domain relative to a linker domain of a wild type Cel7A polypeptide.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: January 28, 2014
    Assignee: Alliance for Sustainable Energy, LLC
    Inventors: William S. Adney, Michael E. Himmel, Stephen R. Decker, Eric P. Knoshaug, Mark R. Nimlos, Michael F. Crowley, Tina Jeoh
  • Patent number: 8637283
    Abstract: A recombinant microorganism employing a bacterial pathway to produce a cyclic amino acid (e.g., coronamic acid or norcoronamic acid) and a plant enzyme (ACC oxidase) to oxidize the amino acid and produce an alkene (e.g., 1-butene or propene) is provided herein. Expression of these two biosynthetic modules in various microbial chassis will facilitate alkene production from diverse energy and carbon sources, including sugars, glycerol, CO2, CH4, H2, and sunlight.
    Type: Grant
    Filed: January 13, 2011
    Date of Patent: January 28, 2014
    Assignee: Mogene LC
    Inventors: Abhay Kumar Singh, Ganesh M. Kishore
  • Patent number: 8609393
    Abstract: Fluorescent proteins comprising the following internal amino acid sequence (SEQ ID NO: 47) Gly Tyr Xaa Xaa Xaa Gln Tyr Leu Pro Xaa Pro 1???????????????5???????????????????10 wherein Xaa in position 3 is Ala or Gly, Xaa in position 4 is Phe, His or Tyr, Xaa in position 5 is His, Tyr or Asn, or Xaa in position 10 is Phe or Tyr are disclosed. Such proteins are e.g. isolated or recombinant fluorescent proteins from a Cephalochordata, such as Branchiostoma floridae or Branchiostoma lanceolatum, or isolated mutants or recombinant proteins that have at least 80% amino acid sequence identity with the fluorescent proteins. Isolated and purified structural genes encoding such fluorescent proteins are also disclosed.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: December 17, 2013
    Assignee: Innoventus Project AB
    Inventor: Olle Israelsson
  • Patent number: 8603785
    Abstract: A dihydrolipoamide dehydrogenase (DLD) in a germ is recombined. The new DLD is applied in a solution to degrade an ether bond of an organic polymer. With the present invention, bioremediation is accomplished without secondary pollution of compounds which have environmental hormones.
    Type: Grant
    Filed: September 18, 2007
    Date of Patent: December 10, 2013
    Assignee: National Central University
    Inventors: Shir-Ly Huang, Yu-Ling Sun
  • Patent number: 8603822
    Abstract: A method for designing a heat-resistant mutant enzyme, the method including the step of reducing a distance between the ?4 helix and the ?6 helix in a protein three-dimensional structure to become smaller than that of a wild type enzyme through deletion, replacement, addition, or insertion of one or several amino acids in the amino acid sequence of the wild type enzyme with respect to tyrosine-dependent short-chain dehydrogenase/reductase.
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: December 10, 2013
    Assignee: Sony Corporation
    Inventors: Daisuke Yamaguchi, Seiji Yamada, Yoshio Goto, Yuichi Tokita
  • Patent number: 8603781
    Abstract: The instant invention is drawn to the methods and compositions necessary to provide recombinant proteins with a substantially reduced or eliminated content of norleucine or other non-standard amino acids. Various embodiments of the invention provide for the substantial elimination of the incorporation of non-standard amino acids into recombinant proteins by the co-expression or enhanced expression of a protein (or the enzymatically active portion thereof) capable of degrading norleucine or other non-standard amino acids, including norvaline, beta-methylnorleucine, and homoisoleucine. In certain particular embodiments of the invention, the norleucine is degraded by a glutamate dehydrogenase, a leucine dehydrogenase, a valine dehydrogenase, a phenylalanine dehydrogenase, a glutamate/leucine/phenylalanine/valine dehydrogenase, or an opine dehydrogenase. Also provided are the cells and DNA constructs for carrying out these methods.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: December 10, 2013
    Assignee: Monsanto Technology LLC
    Inventors: Gregg Bogosian, Julia P. O'Neil, Hong Q. Smith
  • Patent number: 8597916
    Abstract: The present invention concerns multimeric oxidoreductase complexes which function in the enzymatic conversion of a carbon substrate, said complexes having a dehydrogenase subunit and a cytochrome C subunit. The invention further relates to polynucleotides coding for the multimeric complexes and methods of use thereof.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: December 3, 2013
    Assignee: Danisco US Inc.
    Inventors: Robert M. Caldwell, M. Harunur Rashid, Fernando Valle
  • Patent number: 8597901
    Abstract: Described herein are novel nucleic acids, proteins and methods that can be used to provide new catalysts with desirable traits for industrial processes. In particular, novel reductases isolated from the environment using PCR methods are described.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: December 3, 2013
    Assignee: Danisco US Inc.
    Inventors: Mark Donnelly, William H. Eschenfeldt, Jonathan Trent
  • Patent number: 8580720
    Abstract: The present invention relates to a laundry detergent composition comprising a glycosyl hydrolase and a benefit agent containing delivery particles, compositions comprising said particles, and processes for making and using the aforementioned particles and compositions.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: November 12, 2013
    Assignee: The Procter & Gamble Company
    Inventors: Jean-Pol Boutique, Nathalie Jean Marie-Louise Vanwyngaerden, Neil Joseph Lant, Philip Frank Souter, Eugene Steven Sadlowski, Genevieve Cagalawan Wenning
  • Patent number: 8580721
    Abstract: A solid particulate laundry detergent composition including: (a) substituted cellulosic polymer including carboxymethyl substituent groups, and having a degree of substitution (DS) of at least 0.55, and having a degree of blockiness (DB) of at least 0.35, and having a DS+DB is in the range of from 1.05 to 2.00; (b) amylase with greater than 90% identity to the AA560 alpha amylase endogenous to Bacillus sp. DSM 12649 and including: (i) mutations at one or more of positions 9, 149, 182, 186, 202, 257, 295, 299, 323, 339 and 345; and (ii) mutations at four or more of positions 118, 183, 184, 195, 320 and 458; and (c) laundry detergent ingredients.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: November 12, 2013
    Assignee: The Procter & Gamble Company
    Inventors: Michelle Meek, Philip Frank Souter, Neil Joseph Lant, Alan Thomas Brooker, Nigel Patrick Somerville Roberts
  • Patent number: 8574877
    Abstract: The disclosure relates to methods of producing fatty alcohols from recombinant host cells comprising genes encoding heterologous fatty acyl-CoA reductase (FAR) enzymes. The disclosure further relates to FAR enzymes and functional fragments thereof derived from marine bacterium and particularly marine gamma proteobacterium such as Marinobacter and Oceanobacter; polynucleotides encoding the FAR enzymes and vectors and host cells comprising the same.
    Type: Grant
    Filed: June 12, 2012
    Date of Patent: November 5, 2013
    Assignee: Codexis, Inc.
    Inventors: Robert McDaniel, Behnaz Behrouzian, Louis Clark, Douglas A. Hattendorf, Fernando Valle
  • Patent number: 8546118
    Abstract: This invention relates to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In some embodiments, the invention is directed to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides in accordance with the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: October 1, 2013
    Assignee: Verenium Corporation
    Inventors: David P. Weiner, Lishan Zhao, Peter Luginbuhl, Ellen Burke, Toby Richardson, Paula M. Hicks
  • Patent number: 8541191
    Abstract: Provided are hydrolases, including lipases, saturases, palmitases and/or stearatases, and polynucleotides encoding them, and methods of making and using these polynucleotides and polypeptides. Further provided are polypeptides, e.g., enzymes, having a hydrolase activity, e.g., lipases, saturases, palmitases and/or stearatases and methods for preparing low saturate or low trans fat oils, such as low saturate or low trans fat animal or vegetable oils, e.g., soy or canola oils.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: September 24, 2013
    Assignee: Bunge Oils, Inc.
    Inventors: Christopher L. G. Dayton, Tim Hitchman, Katie Kline, Jonathan Lyon, Mark A. Wall, Nelson R. Barton
  • Patent number: 8535928
    Abstract: A novel protease comprising any one of (a) the amino acid sequence of SEQ ID NO: 1, (b) an amino acid sequence having deletion, substitution or addition of one to several amino acids in the amino acid sequence of SEQ ID NO: 1, (c) the amino acid sequence of SEQ ID NO: 3, and (d) an amino acid sequence having deletion, substitution or addition of one to several amino acids in the amino acid sequence of SEQ ID NO: 3, has a high activity under high temperature and high alkaline conditions, a high stability to protein denaturants and surfactants and high effectiveness as a protease used in detergents.
    Type: Grant
    Filed: July 30, 2009
    Date of Patent: September 17, 2013
    Assignee: Osaka University
    Inventors: Shigenori Kanaya, Tita Foophow, Kazufumi Takano, Yuichi Koga
  • Patent number: 8536315
    Abstract: The present invention pertains to a process for production of recombinant arylsulfatase A in a cell culture system, the process comprising culturing a mammalian cell capable of producing rASA in liquid medium in a system comprising one or more bio-reactors; and concentrating, purifying and formulating the rASA by a purification process comprising one or more steps of chromatography. Other aspects of the invention provides a pharmaceutical composition comprising rASA, which is efficiently endocytosed via the mannose-6-phosphate receptor pathway in vivo as well as a rhASA a medicament and use of a rhASA for the manufacture of a medicament for reducing the galactosyl sulphatide levels within target cells in the peripheral nervous system and/or within the central nervous system in a subject.
    Type: Grant
    Filed: January 30, 2005
    Date of Patent: September 17, 2013
    Assignee: Shire Pharmaceuticals Ireland Limited
    Inventors: Jens Fogh, Claes Andersson, Cecilia Weigelt, Christer Moller, Pia Hyden
  • Patent number: 8524483
    Abstract: The object of the present invention is to provide a method for efficiently producing vinegar that contains a higher concentration of acetic acid, wherein a gene involved in the acetic acid fermentation ability is obtained, the acetic acid fermentation ability of an acetic acid bacterium is improved by reducing or deleting the function of the protein encoded by the gene. An acetic acid bacterium with a remarkably improved acetic acid fermentation ability was obtained by obtaining genes encoding an acyl homoserine lactone synthase and an acyl homoserine lactone receptor-type transcription factor that are involved in the quorum-sensing system in the acetic acid bacterium, and modifying the genes so as to reduce or delete the function of the quorum-sensing system. Further provided is a method for more efficiently producing vinegar containing a higher concentration of acetic acid by using the acetic acid bacterium.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: September 3, 2013
    Assignee: Mizkan Group Corporation
    Inventor: Aya Iida
  • Patent number: 8512996
    Abstract: The invention provides a cell for preparing competent cells, wherein the cell is capable of spontaneously accumulating self-producing trehalose therein and the cell is used for the preparation of competent cells. The invention also provides a method for preparing competent cells, including: culturing the cell for preparing the competent cell mentioned previously to obtain a cell suspension; placing the cell suspension into an ice bath; centrifuging the cell suspension to obtain a cell precipitate; mixing a transform reagent with the cell precipitate; and obtaining competent cells suspension.
    Type: Grant
    Filed: December 27, 2010
    Date of Patent: August 20, 2013
    Assignee: Industrial Technology Research Institute
    Inventors: Jia-Hung Wang, Meng-Yin Tsai, Ting-Ting Hung, Kelly Teng